02:21 PM EDT, 08/09/2024 (MT Newswires) -- AN2 Therapeutics ( ANTX ) said Friday it will discontinue phases 2 and 3 of its EBO-301 study of epetraborole, which aims to treat refractory Mycobacterium avium complex lung disease.

Shares sank 59% as intraday trading volume catapulted to more than 9 million versus a daily average of about 157,000.

JPMorgan downgraded Nerdy ( NRDY ) to neutral from overweight, and Raymond James lowered the shares to a market-perform rating from outperform.

In its Q2 results late Thursday, the company reported a decline in gross margin to almost 66% from close to 70% a year ago.

Shares plunged 47% as intraday trading volume soared to over 15.8 million versus the stock's daily average of about 1.33 million.

Telos ( TLS ) shares slumped amid heavy trading after the company reported Friday that Q2 adjusted loss widened from a year ago as revenue slumped year over year.

Shares slumped 45% as intraday trading volume jumped to over 2.6 million from a daily average of roughly 602,000.

Price: 1.08, Change: -1.57, Percent Change: -59.28